Concord medical completes rmb 400 million funding round led by consortium investors

Beijing, aug. 23, 2021 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specializes in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in china, today announced an investment of rmb400.0 million (us$62.2 million) in concord medical's subsidiary, meizhong jiahe medical science & technology development group co., ltd. ("meizhong jiahe") from several investors led by wisdomont asset management (shanghai) co., ltd.
CCM Ratings Summary
CCM Quant Ranking